Your browser doesn't support javascript.
loading
[Fecal microbiota transfer (FMT) in a patient with refractory irritable bowel syndrome]. / Fäkaler Mikrobiom-Transfer bei therapierefraktärem Diarrhoe-betontem Reizdarmsyndrom.
Zoller, Verena; Laguna, Anna-Lena; Prazeres Da Costa, Olivia; Buch, Thorsten; Göke, Burkhard; Storr, Martin.
Afiliação
  • Zoller V; Medizinische Klinik II, Ludwig Maximilians Universität München.
  • Laguna AL; Medizinische Klinik II, Ludwig Maximilians Universität München.
  • Prazeres Da Costa O; Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München.
  • Buch T; Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München.
  • Göke B; Medizinische Klinik II, Ludwig Maximilians Universität München.
  • Storr M; Medizinische Klinik II, Ludwig Maximilians Universität München.
Dtsch Med Wochenschr ; 140(16): 1232-6, 2015 Aug.
Article em De | MEDLINE | ID: mdl-26261935
Irritable bowel syndrome is a disorder of the gastrointestinal tract with unknown etiology. Recent clinical data support a link between changes in fecal microbiota with decreased biodiversity and the development of irritable bowel syndrome. Whether these changes of the microbiota are caused by the disease or whether they develop during the course of the disease remains unclear. Several studies demonstrated that fecal microbiota transfer (FMT) successfully attenuates Clostridium difficile infection by restoring the disturbed bacterial flora of the gut and case reports suggest that FMT may relief symptoms in patients with irritable bowel syndrome (IBS). Here we report a 47-year-old male patient with longstanding refractory diarrhea predominant IBS, who was successfully treated with a single FMT. The beneficial effect on the patient's symptoms was associated with changes of the stool microbiome. Post-FMT the recipient's microbiome resembled the donor's microbiome.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Biológica / Síndrome do Intestino Irritável / Fezes Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: De Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Biológica / Síndrome do Intestino Irritável / Fezes Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: De Ano de publicação: 2015 Tipo de documento: Article